A New York Times investigation last week found that George Yancopoulos, CC ’80, GSAS ’86, VP&S ’87, received exclusive, preferential access to COVID-19 testing during the first wave of the pandemic, when testing supplies were critically limited and cases were surging in New York. Yancopoulos is the president of the pharmaceutical company Regeneron and a major Columbia donor.